abstract |
The present invention provides combination treatments comprising administering compounds that are inhibitors of the pde1 enzyme and other compounds useful in the treatment of neurodegenerative disorders, such as, for example, Alzheimer's disease, Parkinson's disease or Huntington's disease. Separate aspects of the invention are directed to the combined use of said compounds for the treatment of neurodegenerative and / or cognitive disorders. The present invention also provides pharmaceutical compositions comprising said pde1 enzyme inhibitors together with other compounds useful in the treatment of neurodegenerative disorders. |